{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:31:33Z","timestamp":1793694693392,"version":"4.5.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"North South University Internal Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a serious threat to global efforts to combat tuberculosis. Inconsistent findings on the association between HIV infection and MDR-TB were present in many studies. We aimed to review existing data on the relationship between HIV infection and MDR-TB systematically to assess the contribution of HIV on MDR-TB worldwide. We also investigated the patterns of MDR-TB by age, country-wise income, study designs, and global regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We utilized PubMed, Google Scholar, and ScienceDirect databases to select eligible studies for meta-analysis that were published between January 1, 2010, and July 30, 2020. The random-effects model was used to obtain the pooled odds ratio of the crude association between HIV and MDR-TB with a 95% confidence interval. We investigated the potential publication-bias by checking funnel plot asymmetry and using the Egger\u2019s test. Moreover, we assessed the heterogeneity using the\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      statistic. Sensitivity analysis was performed based on sample size and adjustment factors. The protocol was registered with PROSPERO-CRD42019132752.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 1603 studies through a database search, and after subsequent eliminations we selected 54 studies including 430,534\u2009TB patients. The pooled odds of MDR-TB was 1.42 times higher in HIV-positive patients than HIV-negative patients (OR=1.42,CI=1.17\u20131.71,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =75.8%). Subgroup analysis revealed that the estimated pooled odds for South-East Asian countries was 1.86, which is the highest in WHO regions (OR=1.86,CI=1.30\u20132.67,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =0.00%), followed by Europe and Africa. The effect estimate was found to be higher for primary MDR-TB (OR=2.76,CI=1.70\u20134.46,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =0.00%). There was also a trend towards increased odds of MDR-TB for HIV patients older than 40\u2009years (OR=1.56,CI=1.17\u20132.06). The association was found to be significant in high-burden TB countries (OR=1.75, CI=1.39\u20132.19) and in high-income countries (OR=1.55, CI=1.06\u20132.27).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Such findings indicate that HIV infection raises the risk of MDR-TB, and after contrasting it with the results of the earlier pooled study, it appeared to be an upward risk trend. Moreover, we found that the risk is the highest in the South-East Asian region. A balanced allocation of resources is needed to halt both primary and secondary MDR-TB, particularly in HIV infected people with 40\u2009years of age and older.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05749-2","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T14:14:27Z","timestamp":1610374467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zeeba Zahra","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana Ul","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Akhlak-Ul-Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Hasinur Rahman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delwer Hossain","family":"Hawlader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4575-1273","authenticated-orcid":false,"given":"Ahmed","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"5749_CR1","unstructured":"Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329368\/9789241565714-eng.pdf?ua=1 (Accessed 23 July 2020)."},{"key":"5749_CR2","volume-title":"Global tuberculosis report 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013. https:\/\/apps.who.int\/iris\/handle\/10665\/91355 (Accessed 23 July 2020)."},{"key":"5749_CR3","volume-title":"International standards for tuberculosis care","author":"TB CARE I","year":"2014","unstructured":"TB CARE I. International standards for tuberculosis care. 3rd ed. The Hague: TB CARE I; 2014. https:\/\/www.who.int\/tb\/publications\/ISTC_3rdEd.pdf?ua=1 (Accessed 23 July 2020).","edition":"3"},{"key":"5749_CR4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s13104-015-1664-0","volume":"8","author":"D Mekonnen","year":"2015","unstructured":"Mekonnen D, Derbie A, Desalegn E. TB\/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes. 2015;8:666.","journal-title":"BMC Res Notes"},{"key":"5749_CR5","doi-asserted-by":"crossref","first-page":"e56248","DOI":"10.1371\/journal.pone.0056248","volume":"8","author":"H Tweya","year":"2013","unstructured":"Tweya H, Feldacker C, Phiri S, et al. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB\/HIV clinic, Malawi. PLoS ONE. 2013;8:e56248.","journal-title":"PLoS ONE"},{"key":"5749_CR6","doi-asserted-by":"crossref","first-page":"e008273","DOI":"10.1136\/bmjopen-2015-008273","volume":"5","author":"M Rifat","year":"2015","unstructured":"Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG, Milton AH. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open. 2015;5:e008273.","journal-title":"BMJ Open"},{"key":"5749_CR7","first-page":"213","volume":"72","author":"PJ Dolin","year":"1994","unstructured":"Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990\u20132000. Bull World Health Organ. 1994;72:213\u201320.","journal-title":"Bull World Health Organ"},{"key":"5749_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","volume":"18","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018;18:261\u201384.","journal-title":"Lancet Infect Dis"},{"key":"5749_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1469-0691.2004.00758.x","volume":"10","author":"L Aaron","year":"2004","unstructured":"Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect. 2004;10:388\u201398.","journal-title":"Clin Microbiol Infect"},{"key":"5749_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/HIV.S193059","volume":"12","author":"A Singh","year":"2020","unstructured":"Singh A, Prasad R, Balasubramanian V, Gupta N. Drug-resistant tuberculosis and HIV infection: current perspectives. HIV AIDS. 2020;12:9\u201331. https:\/\/doi.org\/10.2147\/HIV.S193059.","journal-title":"HIV AIDS"},{"key":"5749_CR11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","volume":"19","author":"GM Knight","year":"2019","unstructured":"Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect Dis. 2019;19:903\u201312.","journal-title":"Lancet Infect Dis"},{"key":"5749_CR12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009\u201321.","journal-title":"Arch Intern Med"},{"key":"5749_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ijpvm.IJPVM_298_17","volume":"10","author":"P Sharma","year":"2019","unstructured":"Sharma P, Lalwani J, Pandey P, Thakur A. Factors associated with the development of secondary multidrug-resistant tuberculosis. Int J Prev Med. 2019;10:67.","journal-title":"Int J Prev Med"},{"key":"5749_CR14","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1473-3099(18)30537-1","volume":"19","author":"PY Khan","year":"2019","unstructured":"Khan PY, Yates TA, Osman M, et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019;19:e77\u201388.","journal-title":"Lancet Infect Dis"},{"key":"5749_CR15","doi-asserted-by":"crossref","first-page":"e5561","DOI":"10.1371\/journal.pone.0005561","volume":"4","author":"S Suchindran","year":"2009","unstructured":"Suchindran S, Brouwer ES, Van Rie A. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS ONE. 2009;4:e5561.","journal-title":"PLoS ONE"},{"key":"5749_CR16","doi-asserted-by":"crossref","first-page":"e82235","DOI":"10.1371\/journal.pone.0082235","volume":"9","author":"YM Mesfin","year":"2014","unstructured":"Mesfin YM, Hailemariam D, Biadgilign S, Biadglign S, Kibret KT. Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2014;9:e82235.","journal-title":"PLoS ONE"},{"key":"5749_CR17","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"5749_CR18","first-page":"24","volume":"14","author":"RC Brito","year":"2010","unstructured":"Brito RC, Mello FCQ, Andrade MK, et al. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010;14:24\u201333.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR19","doi-asserted-by":"crossref","first-page":"e15735","DOI":"10.1371\/journal.pone.0015735","volume":"5","author":"JR Andrews","year":"2010","unstructured":"Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS ONE. 2010;5:e15735.","journal-title":"PLoS ONE"},{"key":"5749_CR20","first-page":"1424","volume":"14","author":"L Sangar\u00e9","year":"2010","unstructured":"Sangar\u00e9 L, Diand\u00e9 S, Badoum G, Dingtoumda B, Traor\u00e9 AS. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Int J Tuberc Lung Dis. 2010;14:1424\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR21","doi-asserted-by":"publisher","unstructured":"Sangar\u00e9 L, Diand\u00e9 S, Ou\u00e9draogo G, Traor\u00e9 AS. HIV infection and Mycobacterium tuberculosis drug-resistance among tuberculosis patients in Burkina Faso, West Africa. Afr J Clin Exp Microbiol. 2011;12(1). https:\/\/doi.org\/10.4314\/ajcem.v12i1.61047.","DOI":"10.4314\/ajcem.v12i1.61047"},{"key":"5749_CR22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1183\/09031936.00182010","volume":"38","author":"PS Gudo","year":"2011","unstructured":"Gudo PS, Cuna Z, Coelho E, et al. Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey. Eur Respir J. 2011;38:222\u20134.","journal-title":"Eur Respir J"},{"key":"5749_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/00365548.2011.611169","volume":"44","author":"V Vadwai","year":"2012","unstructured":"Vadwai V, Shetty A, Soman RN, Rodrigues CC. Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients. Scand J Infect Dis. 2012;44:48\u201350.","journal-title":"Scand J Infect Dis"},{"key":"5749_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijmyco.2012.07.001","volume":"1","author":"R Macedo","year":"2012","unstructured":"Macedo R, Antunes AF, Villar M, Portugal I. Multidrug and extensively drug-resistant tuberculosis in Lisbon and Vale do Tejo, Portugal, from 2008 to 2010. Int J Mycobacteriol. 2012;1:131\u20136.","journal-title":"Int J Mycobacteriol"},{"key":"5749_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1801.110850","volume":"18","author":"E Sanchez-Padilla","year":"2012","unstructured":"Sanchez-Padilla E, Dlamini T, Ascorra A, et al. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009\u20132010. Emerg Infect Dis. 2012;18:29\u201337.","journal-title":"Emerg Infect Dis"},{"key":"5749_CR26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.5588\/ijtld.11.0122","volume":"16","author":"CL van Halsema","year":"2012","unstructured":"van Halsema CL, Fielding KL, Chihota VN, Lewis JJ, Churchyard GJ, Grant AD. Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002\u20132008. Int J Tuberc Lung Dis. 2012;16:967\u201373.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1471-2334-12-385","volume":"12","author":"PM Ricks","year":"2012","unstructured":"Ricks PM, Mavhunga F, Modi S, et al. Characteristics of multidrug-resistant tuberculosis in Namibia. BMC Infect Dis. 2012;12:385.","journal-title":"BMC Infect Dis"},{"key":"5749_CR28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.5588\/ijtld.11.0522","volume":"16","author":"B Tessema","year":"2012","unstructured":"Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis. 2012;16:805\u201311.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1590\/S0074-02762012000600009","volume":"107","author":"AGV Coelho","year":"2012","unstructured":"Coelho AGV, Zamarioli LA, Telles MA, Ferrazoli L, Waldman EA. A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, S\u00e3o Paulo, Brazil. Mem Inst Oswaldo Cruz. 2012;107:760\u20136.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5749_CR30","doi-asserted-by":"publisher","unstructured":"Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D. Multidrug-resistant tuberculosis in Uzbekistan:results of a nationwide survey, 2010 to 2011. Euro Surveill. 2013;18(42):20609. https:\/\/doi.org\/10.2807\/1560-7917.es2013.18.42.20609. PMID: 24176581.","DOI":"10.2807\/1560-7917.es2013.18.42.20609"},{"key":"5749_CR31","doi-asserted-by":"crossref","first-page":"e53466","DOI":"10.1371\/journal.pone.0053466","volume":"8","author":"J Minion","year":"2013","unstructured":"Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant tuberculosis in Canada 1997\u20132008: demographic and disease characteristics. PLoS ONE. 2013;8:e53466.","journal-title":"PLoS ONE"},{"key":"5749_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-13-137","volume":"13","author":"S Sethi","year":"2013","unstructured":"Sethi S, Mewara A, Dhatwalia SK, et al. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis. 2013;13:137.","journal-title":"BMC Infect Dis"},{"key":"5749_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.5588\/ijtld.12.0703","volume":"17","author":"S van den Hof","year":"2013","unstructured":"van den Hof S, Tursynbayeva A, Abildaev T, et al. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis. 2013;17:526\u201331.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR34","doi-asserted-by":"publisher","unstructured":"Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, Kalamya JN, Awor A, Date A, Joloba ML. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013;8(8):e70763. https:\/\/doi.org\/10.1371\/journal.pone.0070763. PMID: 23936467; PMCID: PMC3731251.","DOI":"10.1371\/journal.pone.0070763"},{"key":"5749_CR35","doi-asserted-by":"publisher","unstructured":"Hang NT, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, Nanri A, Mizoue T, Hoang NP, Cuong VC, Ngoc KT, Sakurada S, Endo H, Keicho N. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PLoS One. 2013;8(8):e71867. https:\/\/doi.org\/10.1371\/journal.pone.0071867. PMID: 23967255; PMCID: PMC3742467.","DOI":"10.1371\/journal.pone.0071867"},{"key":"5749_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2471\/BLT.12.104588","volume":"91","author":"A Skrahina","year":"2013","unstructured":"Skrahina A, Hurevich H, Zalutskaya A, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ. 2013;91:36\u201345.","journal-title":"Bull World Health Organ"},{"key":"5749_CR37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5588\/ijtld.12.0344","volume":"17","author":"H Satti","year":"2013","unstructured":"Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2013;17:100\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/1471-2458-13-782","volume":"13","author":"S Hirpa","year":"2013","unstructured":"Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782.","journal-title":"BMC Public Health"},{"key":"5749_CR39","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.5588\/ijtld.14.0192","volume":"18","author":"Z Mor","year":"2014","unstructured":"Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014;18:1195\u2013201.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2013.09.034","volume":"68","author":"FA Post","year":"2014","unstructured":"Post FA, Grint D, Werlinrud AM, et al. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe. J Infect. 2014;68:259\u201363.","journal-title":"J Infect"},{"key":"5749_CR41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3201\/eid2001.130732","volume":"20","author":"JZ Metcalfe","year":"2014","unstructured":"Metcalfe JZ, Makumbirofa S, Makamure B, et al. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014;20:135\u20137.","journal-title":"Emerg Infect Dis"},{"key":"5749_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijmyco.2015.11.001","volume":"5","author":"N Mohd Shariff","year":"2016","unstructured":"Mohd Shariff N, Shah SA, Kamaludin F. Previous treatment, sputum-smear nonconversion, and suburban living: the risk factors of multidrug-resistant tuberculosis among Malaysians. Int J Mycobacteriol. 2016;5:51\u20138.","journal-title":"Int J Mycobacteriol"},{"issue":"4","key":"5749_CR43","first-page":"697","volume":"46","author":"A Jitmuang","year":"2015","unstructured":"Jitmuang A, Munjit P, Foongladda S. Prevalence and factors associated with multidrug-resistant tuberculosis at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2015;46(4):697\u2013706 PMID: 26867390.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5749_CR44","doi-asserted-by":"publisher","unstructured":"Chuchottaworn C, Thanachartwet V, Sangsayunh P, Than TZ, Sahassananda D, Surabotsophon M, Desakorn V. Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand. PLoS One. 2015;10(10):e0139986. https:\/\/doi.org\/10.1371\/journal.pone.0139986. PMID: 26444421; PMCID: PMC4596622.","DOI":"10.1371\/journal.pone.0139986"},{"key":"5749_CR45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3855\/jidc.6162","volume":"9","author":"OS Elmi","year":"2015","unstructured":"Elmi OS, Hasan H, Abdullah S, Mat Jeab MZ, Bin Alwi Z, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9:1076\u201385.","journal-title":"J Infect Dev Ctries"},{"key":"5749_CR46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2015.08.013","volume":"39","author":"G Mulisa","year":"2015","unstructured":"Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57\u201361.","journal-title":"Int J Infect Dis"},{"key":"5749_CR47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","volume":"15","author":"W Mulu","year":"2015","unstructured":"Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15:368\u201377.","journal-title":"Afr Health Sci"},{"key":"5749_CR48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid2103.141343","volume":"21","author":"G G\u00fcnther","year":"2015","unstructured":"G\u00fcnther G, van Leth F, Alexandru S, et al. Multidrug-resistant tuberculosis in Europe, 2010\u20132011. Emerg Infect Dis. 2015;21:409\u201316.","journal-title":"Emerg Infect Dis"},{"key":"5749_CR49","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3201\/eid2111.150813","volume":"21","author":"JV Ershova","year":"2015","unstructured":"Ershova JV, Volchenkov GV, Kaminski DA, et al. Epidemiology of primary multidrug-resistant tuberculosis, Vladimir Region, Russia. Emerg Infect Dis. 2015;21:2048\u201351.","journal-title":"Emerg Infect Dis"},{"key":"5749_CR50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12889-015-1955-3","volume":"15","author":"K Abdella","year":"2015","unstructured":"Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:599.","journal-title":"BMC Public Health"},{"key":"5749_CR51","volume-title":"Risk factors for multi-drug resistant tuberculosis in Addis Ababa, Ethiopia","author":"F Tadesse","year":"2015","unstructured":"Tadesse F. Risk factors for multi-drug resistant tuberculosis in Addis Ababa, Ethiopia; 2015."},{"key":"5749_CR52","doi-asserted-by":"crossref","first-page":"ofw126","DOI":"10.1093\/ofid\/ofw126","volume":"3","author":"AD Salindri","year":"2016","unstructured":"Salindri AD, Kipiani M, Kempker RR, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis. 2016;3:ofw126.","journal-title":"Open Forum Infect Dis"},{"key":"5749_CR53","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3349\/ymj.2016.57.6.1508","volume":"57","author":"S Lee","year":"2016","unstructured":"Lee S, Lee SH, Mok JH, et al. Is Multi-drug resistant tuberculosis more prevalent in HIV-infected patients in Korea? Yonsei Med J. 2016;57:1508\u201310.","journal-title":"Yonsei Med J"},{"key":"5749_CR54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/IDR.S134369","volume":"10","author":"D Assefa","year":"2017","unstructured":"Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209\u201313.","journal-title":"Infect Drug Resist"},{"key":"5749_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IDR.S126274","volume":"10","author":"A Workicho","year":"2017","unstructured":"Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:91\u20136.","journal-title":"Infect Drug Resist"},{"key":"5749_CR56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/jgid.jgid_167_16","volume":"9","author":"P Sinha","year":"2017","unstructured":"Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of Risk Factors and Drug Resistance Pattern in Tuberculosis Patients in North India. J Global Infect Dis. 2017;9:139\u201345.","journal-title":"J Global Infect Dis"},{"key":"5749_CR57","doi-asserted-by":"crossref","first-page":"e0197737","DOI":"10.1371\/journal.pone.0197737","volume":"13","author":"EA Mesfin","year":"2018","unstructured":"Mesfin EA, Beyene D, Tesfaye A, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE. 2018;13:e0197737.","journal-title":"PLoS ONE"},{"key":"5749_CR58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-018-0283-8","volume":"17","author":"D Gobena","year":"2018","unstructured":"Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Ann Clin Microbiol Antimicrob. 2018;17:30.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5749_CR59","doi-asserted-by":"publisher","DOI":"10.15562\/bmj.v7i1.813","volume-title":"Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary Hospital in North Sumatera, Indonesia","author":"RL Kusumawati","year":"2018","unstructured":"Kusumawati RL, Tania T, Mcneil E, Chongsuvivatwong V. Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary Hospital in North Sumatera, Indonesia; 2018. https:\/\/doi.org\/10.15562\/bmj.v7i1.813."},{"key":"5749_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5588\/ijtld.17.0254","volume":"22","author":"E Pavlenko","year":"2018","unstructured":"Pavlenko E, Barbova A, Hovhannesyan A, et al. Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey. Int J Tuberc Lung Dis. 2018;22:197\u2013205.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5749_CR61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12889-018-5371-3","volume":"18","author":"F Desissa","year":"2018","unstructured":"Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18:422.","journal-title":"BMC Public Health"},{"key":"5749_CR62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.medmal.2018.04.400","volume":"48","author":"BJ Gaborit","year":"2018","unstructured":"Gaborit BJ, Revest M, Roblot F, et al. Characteristics and outcome of multidrug-resistant tuberculosis in a low-incidence area. Med Mal Infect. 2018;48:457\u201364.","journal-title":"Med Mal Infect"},{"key":"5749_CR63","first-page":"1611","volume":"66","author":"KA Alene","year":"2019","unstructured":"Alene KA, Viney K, McBryde ES, Gray DJ, Melku M, Clements ACA. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: a case-control study. Transbound Emerg Dis. 2019;66:1611\u20138.","journal-title":"Transbound Emerg Dis"},{"key":"5749_CR64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2019.02.004","volume":"81","author":"B Baya","year":"2019","unstructured":"Baya B, Achenbach CJ, Kone B, et al. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. Int J Infect Dis. 2019;81:149\u201355.","journal-title":"Int J Infect Dis"},{"key":"5749_CR65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1473-3099(18)30673-X","volume":"19","author":"K Z\u00fcrcher","year":"2019","unstructured":"Z\u00fcrcher K, Ballif M, Fenner L, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis. 2019;19:298\u2013307.","journal-title":"Lancet Infect Dis"},{"key":"5749_CR66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12879-019-4014-3","volume":"19","author":"D Okethwangu","year":"2019","unstructured":"Okethwangu D, Birungi D, Biribawa C, et al. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013\u20132017. BMC Infect Dis. 2019;19:387.","journal-title":"BMC Infect Dis"},{"key":"5749_CR67","first-page":"1","volume":"8","author":"A Fikre","year":"2019","unstructured":"Fikre A, Tewelde T, Shaweno T. Determinants of multi-drug resistant tuberculosis among tuberculosis patients in Southern Ethiopia: a case control study. J Med Bacteriol. 2019;8:1\u201312.","journal-title":"J Med Bacteriol"},{"key":"5749_CR68","doi-asserted-by":"crossref","first-page":"e2019014","DOI":"10.4178\/epih.e2019014","volume":"41","author":"AH Elduma","year":"2019","unstructured":"Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health. 2019;41:e2019014.","journal-title":"Epidemiol Health"},{"issue":"1","key":"5749_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5588\/ijtld.19.0173","volume":"24","author":"MP Chen","year":"2020","unstructured":"Chen MP, Miramontes R, Kammerer JS. Multidrug-resistant tuberculosis in the United States, 2011\u20132016: patient characteristics and risk factors. Int J Tuberc Lung Dis. 2020;24(1):92\u20139. https:\/\/doi.org\/10.5588\/ijtld.19.0173.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"5749_CR70","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/tmi.13409","volume":"25","author":"LH Arroyo","year":"2020","unstructured":"Arroyo LH, Yamamura M, Ramos ACV, et al. Determinants of multidrug-resistant tuberculosis in S\u00e3o Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services. Tropical Med Int Health. 2020;25(7):839\u201349. https:\/\/doi.org\/10.1111\/tmi.13409.","journal-title":"Tropical Med Int Health"},{"issue":"4","key":"5749_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.14745\/ccdr.v46i04a05","volume":"46","author":"T Hirama","year":"2020","unstructured":"Hirama T, Sabur N, Derkach P, et al. Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010\u20132016. Can Commun Dis Rep. 2020;46(4):84\u201392. Published 2020 Apr 2. https:\/\/doi.org\/10.14745\/ccdr.v46i04a05.","journal-title":"Can Commun Dis Rep"},{"key":"5749_CR72","unstructured":"World Bank Country and Lending Groups \u2013 World Bank data help desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups (Accessed 23 Oct 2019)."},{"key":"5749_CR73","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","volume":"3","author":"EA Kendall","year":"2015","unstructured":"Kendall EA, Fofana MO, Dowdy DW. The burden of transmitted multi-drug resistance among epidemics of tuberculosis: a transmission model. Lancet Respir Med. 2015;3:963\u201372.","journal-title":"Lancet Respir Med"},{"key":"5749_CR74","first-page":"e02259","volume":"62","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yuan Z, Shen X, Wu J, Wu Z, Xu B. Time to multidrug-resistant tuberculosis treatment initiation in association with treatment outcomes in Shanghai, China. Antimicrob Agents Chemother. 2018;62:e02259.","journal-title":"Antimicrob Agents Chemother"},{"key":"5749_CR75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thx.2011.160168","volume":"66","author":"T Oni","year":"2011","unstructured":"Oni T, Burke R, Tsekela R, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax. 2011;66:669\u201373.","journal-title":"Thorax"},{"key":"5749_CR76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JDHIV. Tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351\u201376. https:\/\/doi.org\/10.1128\/CMR.00042-10.","journal-title":"Clin Microbiol Rev"},{"key":"5749_CR77","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0028-1085703","volume":"29","author":"WM El-Sadr","year":"2008","unstructured":"El-Sadr WM, Tsiouris SJ. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med. 2008;29:525\u201331.","journal-title":"Semin Respir Crit Care Med"},{"key":"5749_CR78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200503-449OC","volume":"172","author":"A van Rie","year":"2005","unstructured":"van Rie A, Victor TC, Richardson M, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005;172:636\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"5749_CR79","doi-asserted-by":"crossref","first-page":"e70178","DOI":"10.1371\/journal.pone.0070178","volume":"8","author":"M Hanekom","year":"2013","unstructured":"Hanekom M, Streicher EM, de Berg DV, et al. Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent. PLoS ONE. 2013;8:e70178.","journal-title":"PLoS ONE"},{"key":"5749_CR80","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/infdis\/jiw014","volume":"213","author":"T Cohen","year":"2016","unstructured":"Cohen T, Chindelevitch L, Misra R, et al. Within-host heterogeneity of Mycobacterium tuberculosis infection is associated with poor early treatment response: a prospective cohort study. J Infect Dis. 2016;213:1796\u20139.","journal-title":"J Infect Dis"},{"key":"5749_CR81","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","volume":"18","author":"NA Makhado","year":"2018","unstructured":"Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis. 2018;18:1350\u20139.","journal-title":"Lancet Infect Dis"}],"updated-by":[{"DOI":"10.1186\/s12879-021-05799-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05749-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T05:04:27Z","timestamp":1611119067000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05749-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5749"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05749-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"26 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors in this study have any conflict of interest regarding the publication of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}